abs169.txt	background		black	women	with	endometrial	cancer	are	more	likely	to	die	from	theirdisease	compared	to	white	women	with	endometrial	cancer		these	survivaldisparities	persist	even	when	disproportionately	worse	tumor	characteristicsamong	black	women	are	accounted		receipt	of	less	complete	adjuvant	treatmentamong	black	endometrial	cancer	patients	could	contribute	to	this	disparity	objective		we	assessed	the	hypothesis	that	black	women	with	endometrial	cancerare	less	likely	than	their	white	counterparts	to	receive	adjuvant	treatmentwithin	subgroups	defined	by	tumor	characteristics	in	the	nrg	oncology/gynecologyoncology	group	210	study	study	design		our	analysis	included	615	black	and	4	283	white	women	withendometrial	cancer	who	underwent	hysterectomy		women	completed	a	questionnairethat	assessed	race	and	endometrial	cancer	risk	factors		tumor	characteristicswere	available	from	pathology	reports	and	central	review		we	categorized	women	aslow-		intermediate-		or	high-risk	based	on	the	european	society	for	medicaloncology	definition		adjuvant	treatment	was	documented	during	postoperativevisits	and	was	categorized	as	no	adjuvant	treatment	(54	3%)		radiotherapy	only(16	5%)		chemotherapy	only	(15	2%)		and	radiotherapy	plus	chemotherapy	(14	0%)	we	used	polytomous	logistic	regression	to	estimate	odds	ratios	and	95%	confidenceintervals	for	multivariable-adjusted	associations	between	race	and	adjuvanttreatment	in	the	overall	study	population	and	stratified	by	tumor	subtype		stage	or	european	society	for	medical	oncology	risk	category	results		overall		black	women	were	more	likely	to	have	received	chemotherapy-only(odds	ratio=1	40		95%	confidence	interval=1	04-1	86)	or	radiotherapy	pluschemotherapy	(odds	ratio=2	01		95%	confidence	interval=1	54-2	62)	compared	towhite	women	in	multivariable-adjusted	models		no	racial	difference	in	receipt	ofradiotherapy-only	was	observed		in	tumor	subtype-stratified	models		black	womenhad	higher	odds	of	receiving	radiotherapy	plus	chemotherapy	than	white	women	whendiagnosed	with	low-grade	endometrioid	(odds	ratio=2	04		95%	confidenceinterval=1	06-3	93)	or	serous	tumors	(odds	ratio=1	81		95%	confidenceinterval=1	07-3	08)		race	was	not	associated	with	adjuvant	treatment	among	womendiagnosed	with	other	tumor	subtypes		in	stage-stratified	models	we	observed	noracial	differences	in	receipt	of	adjuvant	treatment		in	models	stratified	byeuropean	society	for	medical	oncology	risk	group		black	women	with	high-riskcancer	were	more	likely	to	receive	radiotherapy	plus	chemotherapy	compared	towhite	women	(odds	ratio=1	41		95%	confidence	interval=1	03-1	94)	conclusion		contrary	to	our	hypothesis	we	observed	higher	odds	of	specificadjuvant	treatment	regimens	among	black	as	compared	to	white	women	withinspecific	subgroups	of	endometrial	cancer	characteristics	
